Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Pediatr Gastroenterol Nutr ; 78(6): 1364-1373, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38623928

RESUMO

OBJECTIVES: Paediatric acute liver failure (PALF) is a life-threatening disease. Management aims to support hepatic regeneration or to bridge to liver transplantation. High-volume plasmapheresis (HVP) removes protein-bound substances, alleviates inflammation, and improves survival in adult acute liver failure. However, experience with HVP in PALF is limited. Aim of this study is to report on feasibility, safety, efficacy and outcomes of HVP in PALF. METHODS: Retrospective observational study in children with PALF. HVP was performed upon identification of negative prognostic indicators, in toxic aetiology or multiorgan failure (MOF). Exchanged volume with fresh-frozen plasma corresponded to 1.5-2.0 times the patient's estimated plasma volume. One daily cycle was performed until the patient met criteria for discontinuation, that is, liver regeneration, liver transplantation, or death. RESULTS: Twenty-two children with PALF (body weight 2.5-106 kg) received 1-7 HVP cycles. No bleeding or procedure-related mortality occurred. Alkalosis, hypothermia and reduction in platelets were observed. Haemolysis led to HVP termination in one infant. Seven children (32%) survived with their native livers, 13 patients (59%) underwent liver transplantation. Two infants died due to MOF. Overall survival was 86%. International normalization ratio (INR), alanine aminotransaminases (ALT), bilirubin and inotropic support were reduced significantly (p < 0.05) after the first HVP-cycle (median): INR 2.85 versus 1.5; ALT 1280 versus 434 U/L; bilirubin 12.7 versus 6.7 mg/dL; norepinephrine dosage 0.083 versus 0.009 µg/kg/min. Median soluble-interleukin-2-receptor dropped significantly following HVP (n = 7): 2407 versus 950 U/mL (p < 0.02). CONCLUSIONS: HVP in PALF is feasible, safe, improves markers of liver failure and inflammation and is associated with lowering inotropic support. Prospective and controlled studies are required to confirm efficacy of HVP in PALF.


Assuntos
Falência Hepática Aguda , Transplante de Fígado , Plasmaferese , Humanos , Plasmaferese/métodos , Estudos Retrospectivos , Falência Hepática Aguda/terapia , Falência Hepática Aguda/mortalidade , Masculino , Criança , Feminino , Pré-Escolar , Lactente , Adolescente , Resultado do Tratamento , Estudos de Viabilidade
2.
Pediatr Transplant ; 26(3): e14222, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-34994042

RESUMO

BACKGROUND: Whole liver transplantation in infants <10 kg is a rare procedure with moderate outcomes (67%-79% graft survival at 1 year) and high rates of vascular complications (hepatic artery thrombosis 5-26%). METHODS: Retrospective single-center analysis of whole liver transplantation in infants <10 kg and systematic review of the literature focused on survival rates and surgical complications. RESULTS: Between January 2005 and December 2020, 175 liver transplantations in 173 children were performed at our center. A total of 92 (53%) children weighed less than 10 kg; 19 (21%) of them underwent WLT and constitute the study population. Median age of the recipients was 10 months (21 days-24 months) and median body weight 6.5 (3.1-9.8) kg. Median age of the donors was 5 (1-84) months and median body weight 6.1 (4-21) kg. Median donor-to-recipient body weight ratio was 1.2 (range: 0.6-4.5). Postoperatively, neither hepatic artery nor portal vein thrombosis occurred. A biliary complication occurred in 4 cases: 1 bile leak (early), 3 anastomotic stenoses (1 delayed and 2 late), and 1 non-anastomotic stenosis (late). Patient survival rate at 1, 5, and 10 years was 100%, 92%, and 92%, respectively. Overall, death-censored graft survival after 1, 5, and 10 was 100%. CONCLUSION: Our results are excellent in terms of complications and graft and patient survival. This involves not only high-end surgical performance but also close interdisciplinary perioperative cooperation based on strong standard operating procedures and mainly focused on fluid management, hemostasiology, and strict monitoring of vessel patency.


Assuntos
Hepatopatias , Transplante de Fígado , Trombose , Peso Corporal , Criança , Constrição Patológica/complicações , Sobrevivência de Enxerto , Humanos , Lactente , Hepatopatias/complicações , Transplante de Fígado/métodos , Doadores Vivos , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/prevenção & controle , Estudos Retrospectivos , Trombose/complicações , Trombose/prevenção & controle , Resultado do Tratamento
3.
Psychol Sci ; 18(5): 456-61, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17576287

RESUMO

The present study determined whether central information processing is subject to a circadian rhythm and, therefore, contributes to the well-known time-of-day effect on reaction time (RT). To assess the duration of central processing chronometrically, we employed the psychological refractory period (PRP) paradigm. In this task, subjects make fast responses to two successive stimuli. RT to the second stimulus is usually prolonged as the interval between the two stimuli decreases. This PRP effect is commonly attributed to a central-processing bottleneck. Subjects performed the PRP task every 2 hr during 28 hr of constant wakefulness under controlled conditions. The PRP effect was most pronounced in the early morning. We conclude that central processing is subject to a circadian rhythm, exhibiting a slowing during the night and a nadir in the early morning.


Assuntos
Ritmo Circadiano/fisiologia , Processos Mentais/fisiologia , Desempenho Psicomotor/fisiologia , Tempo de Reação/fisiologia , Estimulação Acústica/métodos , Adulto , Análise de Variância , Humanos , Masculino , Estimulação Luminosa/métodos , Valores de Referência , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA